Ever Supreme Bio Technology Co., Ltd (TPEX: 6712)

Ever Supreme Bio Technology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	265.28	336.44	353.57	641.1	68.88	32
Short-Term Investments	384.5	998.6	915.99	702.6	346.1	562.1
Cash & Short-Term Investments	649.78	1,335	1,270	1,344	414.98	594.1
Cash Growth	-47.55%	5.16%	-5.52%	223.80%	-30.15%	-25.52%
Accounts Receivable	96.25	100.63	84.94	33.66	15.4	5.31
Other Receivables	0.36	0.46	0.88	29.6	2.24	0.34
Receivables	96.61	101.09	85.82	63.27	17.63	5.65
Inventory	104.54	69.09	88.3	56.77	35.49	14.76
Prepaid Expenses	9.55	7.92	6.29	2.11	10.46	12.85
Other Current Assets	0.16	7.73	5.46	0.92	0.07	0.01
Total Current Assets	860.62	1,521	1,455	1,467	478.63	627.36
Property, Plant & Equipment	60.99	64.81	89.84	125.01	171.24	108
Long-Term Investments	815.04	471.31	376.37	333.27	112.51	98.2
Other Intangible Assets	10.09	10.65	11.95	11.14	9.9	9.17
Long-Term Deferred Tax Assets	6.69	1.71	30.32	78.2	80.56	50.33
Other Long-Term Assets	48.57	6.57	9.72	8.22	5.48	17.7
Total Assets	1,802	2,076	1,974	2,023	858.32	910.76
Accounts Payable	26.48	23.33	29.08	15	5.04	1.16
Accrued Expenses	1.72	1.96	3.98	10.49	3.62	1.41
Current Portion of Leases	6.69	5.4	4.5	11.87	9.87	4.11
Current Income Taxes Payable	39.07	46.76	10.47	21.04	-	-
Current Unearned Revenue	131.7	121.65	89.89	12.22	4.12	2.49
Other Current Liabilities	30.02	32.55	25.82	25.9	17.67	19.77
Total Current Liabilities	235.68	231.64	163.74	96.51	40.32	28.93
Long-Term Leases	1.84	0.5	13.36	22.55	33.34	31.76
Long-Term Deferred Tax Liabilities	-	-	3.59	3.82	0.05	0.39
Other Long-Term Liabilities	23.85	0.82	0.76	1.96	3.86	3.76
Total Liabilities	261.37	232.96	181.45	124.83	77.56	64.85
Common Stock	806.73	733.39	681.4	618.18	562.89	560
Additional Paid-In Capital	529.22	785.91	872.22	1,211	486.55	479.95
Retained Earnings	204.68	323.67	238.51	68.74	-300.86	-194.03
Comprensive Income & Other	-	-	0.04	-	32.19	-
Shareholders' Equity	1,541	1,843	1,792	1,898	780.76	845.91
Total Liabilities & Equity	1,802	2,076	1,974	2,023	858.32	910.76
Total Debt	8.53	5.9	17.86	34.42	43.21	35.88
Net Cash (Debt)	641.24	1,329	1,252	1,309	371.77	558.22
Net Cash Growth	-47.74%	6.19%	-4.40%	252.18%	-33.40%	-30.01%
Net Cash Per Share	7.88	16.17	15.10	15.81	4.98	7.49
Filing Date Shares Outstanding	80.67	80.67	82.42	82.25	74.9	74.51
Total Common Shares Outstanding	80.67	80.67	82.42	82.25	74.9	74.51
Working Capital	624.95	1,289	1,292	1,370	438.31	598.43
Book Value Per Share	19.10	22.84	21.74	23.07	10.42	11.35
Tangible Book Value	1,531	1,832	1,780	1,887	770.86	836.75
Tangible Book Value Per Share	18.97	22.71	21.60	22.94	10.29	11.23
Machinery	93.39	91.2	85.39	82.64	104.52	61.8
Leasehold Improvements	65.23	65.23	65.23	63.9	63.64	28.87

Source: S&P Capital IQ. Standard template. Financial Sources.